BENICIA, Calif.--(BUSINESS WIRE)--AcroMetrix, a leading manufacturer of quality control material for clinical diagnostic and blood testing laboratories, announced today the launch of its OptiQual HPV Genotype Panel. Designed to help clinical laboratories comply with CLIA guidelines for qualitative molecular assays that detect Human Papillomavirus (HPV), this addition to AcroMetrix’s line of women’s health products can assist laboratorians with the validation and verification of their molecular HPV tests. Panel members include HPV-16, 18, 68, and a negative, and are offered individually allowing users to customize their own HPV genotyping panel.
